Erratum: Do children have increased susceptibility for developing secondary acute myelogenous leukemia? (Chemico-Biological Interactions (2005) 153-154C (223-229) DOI: 10.1016/j.cbi.2005.03.026);Do children have increased susceptibility for developing secondary acute myelogenous leukemia?

Chemico-Biological Interactions

Volumn 153-154, Issue , 2005, Pages 223-229

  Pyatt, David W ^a,b   Hays, Sean M ^b   Cushing, Colleen A ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b LLP   (United States)

^c EXPONENT INC   (United States)

Author keywords

Benzene; Children; Secondary acute myelogenous leukemia

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BUSULFAN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; MELPHALAN; NITROSOUREA; PREDNISONE; PROCARBAZINE; TENIPOSIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME DELETION; CYTOGENETICS; DOSE RESPONSE; ENZYME INHIBITION; EXPOSURE; HODGKIN DISEASE; HUMAN; RADIATION EXPOSURE; RISK FACTOR;

EID: 20444401589     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.07.001     Document Type: Erratum

References (27)

1. J.H. Jandl Blood, Textbook of Hematology 1997 Little, Brown & Company Boston
2. C.A. Coltman, and S. Dahlberg Treatment-related leukemia N. Engl. J. Med. 322 1990 52 53
3. D.J. Park, and H.P. Koeffler Therapy-related myelodysplastic syndromes Semin. Hematol. 33 1996 256 273
4. J.D. Rowley, and M.M. Le Beau Cytogenetic and molecular analysis of therapy-related leukemia Ann. N.Y. Acad. Sci. 567 1989 130 140
5. B. Johansson, F. Mertens, S. Heim, U. Kristoffersson, and F. Mitelman Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL) Eur. J. Haematol. 47 1991 17 27
6. J.D. Rowley, H.M. Golomb, and J.W. Vardiman Non-random chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease Blood 58 1981 759 767
7. G. Leone, L. Mele, A. Pulsoni, F. Equitani, and L. Pagano The incidence of secondary leukemias Haematologica 84 1999 937 945
8. T.B. Mallory, E.A. Gall, and W.J. Brickley Chronic exposure to benzene (benzol). III. The pathologic results J. Ind. Hyg. Toxicol. 21 1939 355 377
9. M.S. Linet, S.N. Yin, L.B. Travis, C.Y. Li, Z.N. Zhang, D.G. Li, N. Rothman, G.L. Li, W.H. Chow, J. Donaldson, M. Dosemeci, S. Wacholder, W.J. Blot, R.B. Hayes, Y.Z. Wang, T.R. Dai, X.J. Chao, C. Qing, Z.L. Jiang, W.U. Zhang, P.Z. Ye, Q.R. Kou, Y.H. Fan, and X.C. Zhang Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China Environ. Health Perspect. 104 Suppl. 6 1996 1353 1364
10. R. Snyder, and G.F. Kalf A perspective on benzene leukemogenesis Crit. Rev. Toxicol. 24 1994 177 209
11. M. Beaumont, M. Sanz, P.M. Carli, X. Maloisel, L. Thomas, and P. Fenaux Therapy-related acute promyelocytic leukemia J. Clin. Oncol. 21 2003 2123 2137
12. L. Hoffmann, P. Moller, J. Pedersen-Bjergaard, A. Wagge, M. Pedersen, and F.R. Hirsch Therapy-related acute promyelocytic leukemia with t(15;17)(q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature Ann. Oncol. 6 1995 781 788
13. M. Anderson, R. Larson, N. Mauritzson, S. Schnittger, S. Jhanwar, and J. Pedersen-Bjergaard Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop Genes Chromosomes Cancer 33 2002 395 400
14. A. De Renzo, L.F.E. Santoro, R. Notaro, F. Pane, M.R. Buonaiuto, L. Luciano, and B. Rotoli Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II Am. J. Hematol. 60 1999 300 304
15. J. Pedersen-Bjergaard, M.K. Andersen, D.H. Christiansen, and C. Nerlov Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia Blood 99 2002 1909 1912
16. D.T. Bowen Oxidative stress and the myelodysplastic syndromes Leuk. Res. 24 2000 139 140
17. D.J. Paustenbach, P.S. Price, W. Ollison, C. Blank, J.D. Jernigan, R.D. Bass, and H.D. Peterson Re-evaluation of benzene exposure for the pliofilm (rubberworker) cohort (1936-1976) J. Toxicol. Environ. Health 36 1992 177 231
18. L. Rushton, and H. Romaniuk A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom Occup. Environ. Med. 54 1997 152 166
19. M.B. Paxton, V.M. Chinchilli, S.M. Brett, and J.V. Rodricks Leukemia risk associated with benzene exposure in the Pliofilm cohort: I. Mortality update and exposure distribution Risk Anal. 14 1994 147 154
20. O. Wong Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene Occup. Environ. Med. 52 1995 380 384
21. L. Zhang, D. Eastmond, and M. Smith The nature of chromosomal aberrations detected in humans exposed to benzene Crit. Rev. Toxicol. 32 2002 1 42
22. M.T. Smith, L.P. Zhang, Y.X. Wang, R.B. Hayes, G.L. Li, J. Wiemels, M. Dosemeci, N. Titenko-Holland, L.Q. Xi, P. Kolachana, S.N. Yin, and N. Rothman Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene Cancer Res. 58 1998 2176 2181
23. L.P. Zhang, N. Rothman, Y.X. Wang, R.B. Hayes, W. Bechtold, P. Venkatesh, S.N. Yin, Y.Z. Wang, M. Dosemeci, G.L. Li, W. Lu, and M.T. Smith Interphase cytogenetics of workers exposed to benzene Environ. Health Perspect. 104 Suppl. 6 1996 1325 1329
24. C. Pui, M. Hancock, S. Raimondi, D. Head, E. Thompson, J. Wilimas, L. Kun, L. Bowman, W. Christ, and C. Pratt Myeloid neoplasia in children treated for solid tumours Lancet 336 1990 417 421
25. M. Tucker, A. Meadows, J. Boice, M. Stovall, O. Oberlin, B. Stone, J. Birch, P. Voute, R. Hoover, and J. Fraumeni Leukemia after therapy with alkylating agents for childhood cancer J. Natl. Cancer Inst. 78 1987 459 464
26. N.J. Winick, R.W. McKenna, J.J. Shuster, N.R. Schneider, M.J. Borowitz, W.P. Bowman, D. Jacaruso, B.A. Kamen, and G.R. Buchanan Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide J. Clin. Oncol. 11 1993 209 217
27. M. Deley, T. Leblanc, A. Shamsaldin, M. ARaguin, B. Lacour, D. Sommelet, A. Chompret, J. Cayuela, C. Bayle, A. Bernheim, F. Vathaire, G. Vassal, and C. Hill Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthrcyclines: a case-control study by the Societé Francaise d'Oncologie Pediatrique J. Clin. Oncol. 21 2003 1074 1081